Katjana Schwab

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Genome Wide Analysis

Health Promotion

Top Venues

Cell death discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Katjana Schwab, Konstantin Riege, Luis Coronel, Clara Stanko, Silke Förste, Steve Hoffmann, Martin Fischer
p53 target ANKRA2 cooperates with RFX7 to regulate tumor suppressor genes. Cell death discovery 10 (1) (2024)
Katjana Schwab, Konstantin Riege, Luis Coronel, Clara Stanko, Silke Förste, Steve Hoffmann, Martin Fischer
p53 target ANKRA2 cooperates with RFX7 to regulate tumor suppressor genes. Cell death discovery 10 (1) (2024)
Katjana Schwab, Luis Coronel, Konstantin Riege, Erika K Sacramento, Norman Rahnis, David Häckes, Emilio Cirri, Marco Groth, Steve Hoffmann, Martin Fischer
Multi-omics analysis identifies RFX7 targets involved in tumor suppression and neuronal processes. Cell death discovery 9 (1) (2023)
Katjana Schwab, Luis Coronel, Konstantin Riege, Erika K Sacramento, Norman Rahnis, David Häckes, Emilio Cirri, Marco Groth, Steve Hoffmann, Martin Fischer
Multi-omics analysis identifies RFX7 targets involved in tumor suppression and neuronal processes. Cell death discovery 9 (1) (2023)
Katjana Schwab, Luis Coronel, Konstantin Riege, Erika K Sacramento, Norman Rahnis, David Häckes, Emilio Cirri, Marco Groth, Steve Hoffmann, Martin Fischer
Multi-omics analysis identifies RFX7 targets involved in tumor suppression and neuronal processes. Cell death discovery 9 (1) (2023)
Luis Coronel, David Häckes, Katjana Schwab, Konstantin Riege, Steve Hoffmann, Martin Fischer
p53-mediated AKT and mTOR inhibition requires RFX7 and DDIT4 and depends on nutrient abundance. Oncogene 41 (7) (2021)